Publication | Open Access
Gemcitabine versus bacille Calmette‐Guérin after initial bacille Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer
180
Citations
16
References
2010
Year
Gemcitabine might represent a second-line treatment option after BCG failure in high-risk non-muscle-invasive BC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1